Alprolix Kit
Product Images NDC 71104-911

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Alprolix (NDC 71104-911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bioverativ Therapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Alp0b 0002 01)

An instructional illustration showing a person holding a vial or container and peeling back a protective foil seal or cover from the top, likely as part of the preparation or administration steps for ALPROLIX, a coagulation factor IX recombinant Fc fusion protein kit by Bioverativ Therapeutics Inc.*

FDA Label Image

Figure (Alp0b 0002 02)

An instructional illustration showing a hand pressing down on a vial top, suggesting a step to open or activate it. The image appears to demonstrate part of the preparation process for the ALPROLIX kit containing Coagulation Factor IX (Recombinant), Fc Fusion Protein by Bioverativ Therapeutics Inc.*

FDA Label Image

Figure (Alp0b 0002 03)

An instructional diagram showing hands removing the protective cap from a vial, demonstrating preparation of the ALPROLIX coagulation factor IX recombinant Fc fusion protein kit for use.*

FDA Label Image

Figure (Alp0b 0002 04)

An instructional illustration showing a hand twisting or securing a syringe cap or plunger onto a syringe barrel, indicating a step in medication preparation or administration.*

FDA Label Image

Figure (Alp0b 0002 05)

An instructional illustration showing the contents of the ALPROLIX kit, including a vial adapter in its package, a vial with powdered drug, and a prefilled diluent syringe with a plunger rod.*

FDA Label Image

Figure (Alp0b 0002 06)

An instructional illustration showing two sequential steps for opening a vial: first twisting off a protective cap, and second, lifting a stopper from the vial. The drawing features simplified hands performing these actions.*

FDA Label Image

Figure (Alp0b 0002 07)

An instructional illustration showing a hand opening a sterile foil pouch, removing a white item from inside, and holding a clear plastic cup. The image instructs on how to open the foil pouch and remove its contents, likely related to preparation of the ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein Kit by Bioverativ Therapeutics Inc.*

FDA Label Image

Figure (Alp0b 0002 08)

An instructional diagram showing hands pressing down on a clear cylindrical component, likely demonstrating a step in preparing or using the ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein kit by Bioverativ Therapeutics Inc.*

FDA Label Image

Figure (Alp0b 0002 09)

An instructional illustration showing the removal of a flip-off cap from a vial. One hand holds the vial while the other hand lifts the flip-off cap upward, demonstrating the proper technique for opening the vial prior to use.*

FDA Label Image

Figure (Alp0b 0002 10)

An instructional illustration showing the connecting of a syringe to a vial adapter for medication preparation. A hand holds the syringe, aligning it with the vial adapter, indicated by purple arrows to demonstrate the connection process, relevant for use in preparing ALPROLIX KIT.*

FDA Label Image

Figure (Alp0b 0002 11)

An illustration showing a hand holding a syringe by the barrel, with the thumb and forefinger gripping near the top. The syringe appears empty and is shown upright. This image is likely part of a kit for ALPROLIX, Coagulation Factor IX (Recombinant), Fc Fusion Protein.*

FDA Label Image

Figure (Alp0b 0002 12)

An instructional diagram showing two hands preparing a dose from a vial using a syringe. One hand holds the vial steady while the other removes the cap from the vial's rubber stopper. An arrow indicates the removal direction of the cap.*

FDA Label Image

Figure (Alp0b 0002 13)

An instructional illustration showing hands rotating the cap of a dosing syringe, likely part of a medical kit for dose preparation or administration.*

FDA Label Image

Figure (Alp0b 0002 14)

An instructional illustration showing hands assembling or preparing a syringe by attaching it to a vial or container, with a purple downward arrow indicating the direction for insertion. The image relates to the preparation of a medication kit, likely the ALPROLIX coagulation factor IX (recombinant) Fc fusion protein kit.*

FDA Label Image

Figure (Alp0b 0002 15)

An instructional illustration showing a hand holding a syringe connected to a vial. The hand is performing a twisting motion to the vial indicated by purple arrows, suggesting the step of mixing or securing the vial, likely part of the preparation process for ALPROLIX (Coagulation Factor IX, Recombinant, Fc Fusion Protein) kit.*

FDA Label Image

Figure (Alp0b 0002 16)

An instructional illustration showing two steps for preparing a medication kit: the first step depicts holding a vial and syringe with an arrow pointing downward; the second step shows the syringe being pulled down with a downward arrow, indicating the drawing of a solution into the syringe.*

FDA Label Image

Figure (Alp0b 0002 17)

An instructional illustration showing hands reconstituting a medication vial by attaching a syringe to the vial's cap. The image demonstrates rotating the syringe connection to the vial, likely as part of preparing ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein kit for administration.*

FDA Label Image

Figure (Alp0b 0002 18)

An instructional illustration showing a hand attaching a syringe needle to a vial, indicating a twisting motion to secure the needle. The image is likely part of preparation steps for a product kit.*

FDA Label Image

Figure (Alp0b 0002 19)

An instructional illustration showing a hand holding a syringe and attaching it to a vial or container. The syringe is shown with a purple arrow indicating a twisting or turning motion, suggesting assembly or preparation of the injection device.*

FDA Label Image

Figure (Alp0b 0002 20)

An instructional illustration showing a hand holding a syringe, positioned above a vial or container, with a downward-pointing arrow indicating the direction of pressing or attaching the syringe. The image depicts a step in the preparation or administration process for the ALPROLIX coagulation factor IX kit.*

FDA Label Image

Figure (Alp0b 0002 21)

An instructional illustration showing two hands preparing a syringe. One hand holds the syringe barrel with a purple plunger, and the other hand is holding a vial or stopper, suggesting the process of reconstituting or drawing medication. A small cap is shown beside the syringe setup, likely indicating preparation steps for medication administration.*

FDA Label Image

Figure (Alp0b 0002 22)

An illustration showing a person using their fingers to apply pressure to the inner side of their opposite forearm, near the wrist. The diagram depicts the action of pressing on a pulse point.*

FDA Label Image

Figure (Alp0b 0002 23)

An instructional illustration showing hands demonstrating how to connect or handle two parts of a medical device, possibly a syringe and vial adapter. The image includes a curved tube and an arrow indicating a motion to connect the components.*

FDA Label Image

Figure (Alp0b 0002 24)

An instructional illustration showing a person using their hands to insert a needle or catheter into a vein on the forearm, depicting a step in intravenous access or injection technique.*

FDA Label Image

Figure (Alp0b 0002 25)

An instructional illustration showing a hand holding a syringe and injecting into a vein in the forearm, demonstrating an intravenous injection procedure. An arrow indicates the motion of drawing liquid into the syringe.*

FDA Label Image

Figure (Alp0b 0002 26)

An instructional illustration showing a hand cleaning the forearm with a cotton swab or pad, likely indicating preparation for an injection or medical procedure on the arm.*

FDA Label Image

Principal Display Panel (250 IU Nominal Carton Label)

ALPROLIX 500 IU Nominal kit packaging label for Coagulation Factor IX (Recombinant), Fc Fusion Protein, designed for intravenous administration. The label shows contents including a single-use vial with lyophilized powder, a prefilled diluent syringe, sterile vial adapter, and package insert. Manufactured by Bioverativ Therapeutics Inc., Waltham, MA, with storage and reconstitution instructions and a barcode included.*

FDA Label Image

Principal Display Panel (500 IU Nominal Carton Label)

ALPROLIX 1000 IU Nominal kit packaging label for Coagulation Factor IX (Recombinant), Fc Fusion Protein. The label shows it is for intravenous administration and includes components of the kit: a single-use vial with lyophilized powder, a prefilled diluent syringe, and a vial adapter device. Manufactured by Bioverativ Therapeutics Inc. The label also contains storage instructions and a barcode, along with the NDC number 71104-922-01.*

FDA Label Image

Principal Display Panel (1000 IU Nominal Carton Label)

ALPROLIX kit packaging label for Coagulation Factor IX (Recombinant), Fc Fusion Protein, 2000 IU nominal strength. The label indicates it is for intravenous administration and includes one single-use vial with lyophilized powder, one prefilled diluent syringe, one sterile vial adapter, and a package insert. The labeler is Bioverativ Therapeutics Inc., Waltham, MA. Storage instructions and dosage information are also shown.*

FDA Label Image

Principal Display Panel (2000 IU Nominal Carton Label)

ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein kit packaging label by Bioverativ Therapeutics Inc. The label specifies the product as a plasma derivative for intravenous administration with a nominal strength of 3000 IU. It includes storage instructions, package contents, NDC number 71104-944-01, usage directions, and manufacturer information. The label features a predominantly white background with navy and green accent panels.*

FDA Label Image

Principal Display Panel (3000 IU Nominal Carton Label)

ALPROLIX 250 IU Nominal kit packaging label for Coagulation Factor IX (Recombinant), Fc Fusion Protein, for intravenous administration. The label includes dosage and administration instructions, manufacturer Bioverativ Therapeutics Inc., and product contents such as single-use vial with lyophilized powder, prefilled diluent syringe, vial adapter, and package insert. UPC barcode and lot-specific information areas are also visible.*

FDA Label Image

Principal Display Panel (4000 IU Nominal Carton Label)

The packaging label for ALPROLIX, a kit containing Coagulation Factor IX (Recombinant), Fc Fusion Protein for intravenous administration. The label states a nominal strength of 4000 IU. It lists contents: one single-use vial with lyophilized powder, one prefilled diluent syringe of 5 mL sterile solution, one sterile vial adapter, and package insert. Manufactured by Bioverativ Therapeutics Inc., with storage and dosage instructions provided. The label includes the NDC 71104-977-01 and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.